المؤلفون: Jia‐Xin Liu, Xin Liu, Yong Yang, Wei‐Ping Liu, Ying Wang, Xia He, Li‐Ling Zhang, Bao‐Lin Qu, Li‐Ting Qian, Xiao‐Rong Hou, Xue‐Ying Qiao, Hua Wang, Gao‐Feng Li, Yuan Zhu, Jian‐Zhong Cao, Jun‐Xin Wu, Tao Wu, Su‐Yu Zhu, Mei Shi, Hui‐Lai Zhang, Hang Su, Yu‐Jing Zhang, Jun Zhu, Shu‐Nan Qi, Ye‐Xiong Li, Yu‐Qin Song

المصدر: Cancer Reports, Vol 6, Iss 5, Pp n/a-n/a (2023)

مصطلحات موضوعية: asparaginase/therapeutic use, efficacy, physiopathology, retrospective analysis, T cell lymphoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2573-8348

URL الوصول: https://doaj.org/article/ff3ac48efb1f455c88da07260ec2435a

المؤلفون: Tosta Pérez, María, Herrera Belén, Lisandra, Letelier, Pablo, Calle, Yolanda, Pessoa, Adalberto, Farías, Jorge G

المصدر: Tosta Pérez , M , Herrera Belén , L , Letelier , P , Calle , Y , Pessoa , A & Farías , J G 2023 , ' L-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review ' , Medical oncology (Northwood, London, England) , vol. 40 , no. 5 , pp. 150 . https://doi.org/10.1007/s12032-023-02014-9

مصطلحات موضوعية: Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy, Asparaginase - therapeutic use - adverse effects, Drug-Related Side Effects and Adverse Reactions, Immunogenicity, Acute lymphoblastic leukemia, Hypersensitivity, Asparaginase, Drug Hypersensitivity, Humans, Child, Antineoplastic Agents - adverse effects, Antineoplastic agent

الاتاحة: https://pure.roehampton.ac.uk/portal/en/publications/b3d2e737-02ba-4084-b09c-cd032caf5c53
https://doi.org/10.1007/s12032-023-02014-9

المؤلفون: Verkerk, Karlijn, Otten, Hans-Martin, Huitema, Alwin D R

المساهمون: Apotheek O&O&O, Cancer

مصطلحات موضوعية: Antineoplastic Agents/therapeutic use, Asparaginase/therapeutic use, Brain Diseases/chemically induced, Cisplatin, Cisplatin/adverse effects, Cytarabine/adverse effects, Deoxycytidine/analogs & derivatives, Fluorouracil, Gemcitabine, Humans, Hyperammonemia, Hyperammonemia/chemically induced, Hyperammonemic encephalopathy, Neurotoxicity Syndromes/drug therapy, Case Reports, Journal Article

وصف الملف: application/pdf

Relation: https://dspace.library.uu.nl/handle/1874/448197

الاتاحة: https://dspace.library.uu.nl/handle/1874/448197

المؤلفون: Stams, W.A. (Wendy), Boer, M.L. (Monique) den, Holleman, A. (Amy), Appel, I.M. (Inge), Beverloo, H.B. (Berna), Wering, E.R. (Elisabeth) van, Janka-Schaub, G.E. (Gritta), Evans, W.E. (William), Pieters, R. (Rob)

المصدر: Blood

مصطلحات موضوعية: Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic, Asparaginase/*therapeutic use, Aspartate-Ammonia Ligase/analysis/*genetics, Child, Core Binding Factor Alpha 2 Subunit, Disease-Free Survival, Humans, Leukemia, B-Cell, Acute/drug therapy/mortality, Lymphocytic, Acute/drug therapy/*mortality, Oligonucleotide Array Sequence Analysis, Oncogene Proteins, Fusion/analysis, Prognosis, Recurrence, Research Support, Non-U.S. Gov't

وصف الملف: application/pdf

Relation: http://repub.eur.nl/pub/8226; urn:hdl:1765/8226

الاتاحة: http://repub.eur.nl/pub/8226

المؤلفون: Gerrard, M., Cairo, MS, Weston, C., Auperin, A., Pinkerton, C Ross, Lambilliote, A., Sposto, R., McCarthy, K., Lacombe, MJ, Perkins, S.L., Patte, Catherine, Sariban, Eric

المصدر: British journal of haematology, 141 (6

مصطلحات موضوعية: Sciences bio-médicales et agricoles, Adolescent, Antineoplastic Combined Chemotherapy Protocols -- adverse effects, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Asparaginase -- adverse effects, Asparaginase -- therapeutic use, Child, Preschool, Combined Modality Therapy, Cyclophosphamide -- adverse effects, Cyclophosphamide -- therapeutic use, Cytarabine -- adverse effects, Cytarabine -- therapeutic use, Doxorubicin -- adverse effects, Doxorubicin -- therapeutic use, Female, Follow-Up Studies, Humans, Infant, Lymphoma, B-Cell -- drug therapy, B-Cell -- pathology, B-Cell -- surgery, Male, Methotrexate -- adverse effects, Methotrexate -- therapeutic use, Neoplasm Staging, Prednisone -- adverse effects, Prednisone -- therapeutic use, Survival Analysis

وصف الملف: 1 full-text file(s): application/pdf

Relation: uri/info:doi/10.1111/j.1365-2141.2008.07144.x; uri/info:pii/BJH7144; uri/info:pmid/18371107; https://dipot.ulb.ac.be/dspace/bitstream/2013/57759/3/57759.pdf; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/57759

الاتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/57759
https://dipot.ulb.ac.be/dspace/bitstream/2013/57759/3/57759.pdf

المؤلفون: Ceppi, F., Gagné, V., Douyon, L., Quintin, C.J., Colombini, A., Parasole, R., Buldini, B., Basso, G., Conter, V., Cazzaniga, G., Krajinovic, M.

المصدر: Pharmacogenomics, vol. 19, no. 2, pp. 105-112

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Asparaginase/therapeutic use, Biomarkers, Tumor/genetics, Child, DNA/genetics, Daunorubicin/therapeutic use, Disease-Free Survival, Female, Haplotypes/genetics, Humans, Male, Methotrexate/therapeutic use, Polymorphism, Genetic/genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics, Prednisone/therapeutic use, Promoter Regions, Tetrahydrofolate Dehydrogenase/genetics, Treatment Outcome, Vincristine/therapeutic use, childhood ALL, dihydrofolate reductase polymorphisms

Relation: info:eu-repo/semantics/altIdentifier/pmid/29210328; info:eu-repo/semantics/altIdentifier/eissn/1744-8042; https://serval.unil.ch/notice/serval:BIB_CE42BB1FCCE7; urn:issn:1462-2416

الاتاحة: https://serval.unil.ch/notice/serval:BIB_CE42BB1FCCE7
https://doi.org/10.2217/pgs-2017-0153